人工智能能从分子机制层面教会我们什么?
该综述讨论分子影像中医学图像隐含特征与疾病分子机制的关系,并阐述人工智能(AI)与机器学习(ML)在解析这些特征中的作用。文章以非小细胞肺癌为范例,汇总文献中已应用AI和ML方法研究的分子与细胞过程,指出AI有助于以快速、可重复和透明的方式处理日益增大的医学图像数据。
要点
- 医学图像中除宏观分子机制外还存在可改善肿瘤表征、治疗预测与预后判断的附加特征。
- 放射组学已显示可个性化并改善患者管理与结局,但其与疾病分子机制的关系尚不明确。
- AI与ML方法已在非小细胞肺癌等肿瘤中用于研究分子和细胞过程。
核心结论
- 医学图像中的附加特征与疾病分子机制的关系尚不明确,AI可能有助于解析并以快速、可重复和透明的方式处理日益增大的医学图像数据。
研究设计与样本
- 综述类文章,以非小细胞肺癌为范例,汇总文献中已应用AI和ML方法研究的分子与细胞过程。
主要发现
- 早期报道已揭示放射组学可个性化并改善患者管理与结局。
- AI涵盖语言处理、知识表示、问题求解和规划等由计算机执行的智能功能。
- 基于规则的算法(如计算机辅助诊断)自1990年代起已用于医学影像,AI兴趣回升与计算能力提升和机器学习进展有关。
临床怎么用
- 临床可利用AI和ML方法处理医学图像及之外日益增大的数据,以快速、可重复和透明的方式支持临床实践。
局限性
- 医学图像中附加指标与疾病底层分子机制的关系尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While molecular imaging with positron emission tomography or single-photon emission computed tomography already reports on tumour molecular mechanisms on a macroscopic scale, there is increasing evidence that there are multiple additional features within medical images that can further improve tumour characterization, treatment prediction and prognostication. Early reports have already revealed the power of radiomics to personalize and improve patient management and outcomes. What remains unclear is how these additional metrics relate to underlying molecular mechanisms of disease. Furthermore, the ability to deal with increasingly large amounts of data from medical images and beyond in a rapid, reproducible and transparent manner is essential for future clinical practice. Here, artificial intelligence (AI) may have an impact. AI encompasses a broad range of 'intelligent' functions performed by computers, including language processing, knowledge representation, problem solving and planning. While rule-based algorithms, e.g. computer-aided diagnosis, have been in use for medical imaging since the 1990s, the resurgent interest in AI is related to improvements in computing power and advances in machine learning (ML). In this review we consider why molecular and cellular processes are of interest and which processes have already been exposed to AI and ML methods as reported in the literature. Non-small-cell lung cancer is used as an exemplar and the focus of this review as the most common tumour type in which AI and ML approaches have been tested and to illustrate some of the concepts.
引用
- Cook GJR, Goh V. What can artificial intelligence teach us about the molecular mechanisms underlying disease? Eur J Nucl Med Mol Imaging. 2019. PMID: 31190176. doi:10.1007/s00259-019-04370-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。